This study from Ethiopia is liable to make an important contribution to the scant evidence-base regarding determinants of LTFU in context STIs. Such evidence is needed as to better identify targets for interventions that aim to effectively reduce LTFU, and following, improve treatment and prevention of STIs. The study provides good sample sizes to describe LTFU and I acknowledge the authors for investigating both highly relevant person characteristics as well as facility-level factors as potential determinants of LTFU. While providing as such good quality results, the paper unfortunately holds major shortcomings in structure, logic and writing, particularly impacting the Introduction and Discussion. These issues appear, in my view, resolvable in a revision.
Specific comments 1) INTRODUCTION
The introduction needs some restructuring in order to strengthen the present focus on LTFU in STIs, mentioning partner notification (PN), the apparent motivation behind the principal study, only to contextualize and emphasize the relevance of the present research. Three successive paragraphs could concentrate on the following:
1.1) Introducing that LTFU presents a major problem to public health policies targeting the treatment and prevention of STIs using argumentation along the lines indicated above (thus containing topics of §2 and §3 from current manuscript).
1.2) Outline the established and potential risk factors for LTFU, with respect to durable STI treatment, grouped by individual (current lines 35-42) and facility-level factors (e.g., current lines 30-33). This section should be expanded on, with additional literature references as to provide a better rationale for the set of potential determinants of LTFU chosen in this present study (i.e., variables shown in Tables  1 and 3 ).
1.3) Brief outline of the setting of the current study, followed by aims and objectives. Details to the STI treatment guidelines and use of a syndromic management approach are better dealt with in the Methods section; the same applies to the use of multilevel modeling (lines 50-53).
2) METHODS
The Methods section also needs restructuring and some specific additional information to the study. Broader sections may successively include the following: 2.1) General description of setting. For instance, lines 37-41 should be moved to this section, also study site selection should be explained. It only became clear that the study involved 27 facilities only in Figure 1. 2.2) Description of presentation and identification of cases, including a brief explanation of operational diagnostics and treatment guidelines (syndromic management approach). Importantly, some detail needs to be provided regarding the different STIs that are being managed.
2.3) Details regarding study design and the recruitment and followup of study participants. Here procedures regarding informed consent should also be described in more detail. ("… volunteer to participate in the study … " in line 19 is too vague). The sample size calculation also needs clarification: it is unclear what is meant with " … an odds ratio of 1.5 at 95% CI …" or "… a power of 80% with a response rate of 20% …" (lines 43-46).
2.4) Details to the questionnaire tool that is being used are needed. In line with a renewed Introduction, a clear distinction between individual-and facility-level predictors for LTFU in STI treatment is desirable . Particularly the parameters in Table 1 need more explanation. To understand and judge the usefulness of the tools used, a brief summary is needed regarding the exact construct of each of the multi-item elements (e.g., STI transmission apparently containing 5 items; STI symptoms 6 items; etc) as well as available evidence from metric studies for their validity (in case as an Appendix). Importantly, the index score for health facilities from the Regional Health Bureau needs explanation and specification, in particular attest confirm that LTFU was not included in the quality index.
2.5) Statistical analysis. All text regarding the definition of LTFU is best shifted to the start of this section (thus also lines 30-35). Then provide detail regarding the descriptive analysis, followed by the multivariable analysis. The hierarchical levels used in the current analysis, presumably facility-and patient-level , need better explaining. Furthermore, a rationale for the choice of predictors variables is needed, particularly why certain variables (e.g., Distance or Guideline; Table 1 ) were apparently excluded as potential predictors for LTFU in the data analysis (compared with Table 3 ). Also an explanation and justification for the use of binarytransformed scores (Table 1 ) in data analysis is lacking.
3) RESULTS
Main issues concern the following:
3.1) Figure 1 can be dropped. All relevant information is already available in Table 2 , with the exception of the number of clinic sites where data were collected. See above, Methods issue I.
3.2) I strongly suggest to add "type of STI" as a variable in descriptive Table 2 , and additionally to the multivariable analyses in Table 3 . This background info is highly relevant to the paper. It further seems highly plausible that risk for LTFU is related type of STI, also that STI type may thus represent a confounder for the some of the documented associations (Table 3) , for instance for perceived stigma (not excluding other variables).
3.3) What is the reasoning behind using "marital status" and "No. of partners" as independent variables in analyses (Tables 2 & 3) ? Aren"t these variables highly correlated? This could use some justification in the Methods section, data analysis plan. Table 2 : "No (%)" column for LTFU can be dropped; the header "Lost to follow-up" can also be dropped, presuming that the column "Entire cohort (%)" also refers to n (%) LTFU. It would be informative to add a column presenting a univariable comparison of LTFU rates (p-values from chi-square tests). There also needs to be a space in between n and (%). Table 3 : I strongly suggest to drop Models 1-3 from the table. The fact that effect sizes for individual and facility-level factors are only slightly mutually affected can be briefly mentioned in the Results. Test statistics should be given in detail, instead of using star "*" symbols, and row-wise aligned to the overall variable name (representing a global test, see next point; e.g. global test is for sex of index case, not male). Table 3 : Regarding significance testing, it is important to perform global tests to evaluate the contribution of a specific variable. This particularly concerns variables with more than one level, such as "educational status": the present test statistic is only comparing "Illiterate" vs. "College+". Instead a global test with 3 degrees of freedom is initially needed, followed by a post-hoc test in case of global significance. The post-hoc test needs to account for multiple testing (e.g., using Bonferroni correction). In Stata, one can use commands "contrast" or "pwcompare".
3.4)

3.5)
3.6)
3.7) Table 3 : Several potential predictor variables for LTFU do not appear in Table 3 , e.g., "age" and "distance to clinic" (not excluding other omitted variables). Why is this the case? If a stepwisebackward selection procedure was used to reduce the initial full model to a final model, containing only significant (alpha 0.05) variables, then this needs to be explained in the Methods section. Also, for transparency it would be important to report the significance level at which these variables were dropped in the Results section.
4) DISCUSSION
4.1) The Discussion would benefit from a restructuring. Following an overall summary of the revised results, a contextual discussion of the overall rates of LTFU in persons with STIs are needed. In referencing other studies, it is highly relevant to specify the type of STI involved (e.g., HIV, gonorrhea, etc), as the dynamics of LTFU may vary. Next, a more focused discussion should follow on individual level and facility level variables, highlighting the Results of the multivariable analysis in Table 3 (taking point 4.2 into account). The limitations section also needs the author"s attention, as it contains inaccurate phrasings (e.g., line 23) and an implausibility e.g., line 24-26: the argument regarding "… lack of uniform definition on LTFU … " that seems to conflict with the uniform definition of the 1 week delay expained in the Methods section.
4.2) A fundamental problem in the current discussion is the use of perceived stigma (or further specific variables), in explaining the association of other variables, e.g. sex (lines 27-32) or education (lines 35-44) with LTFU. However, because inferences regarding associations were in the presence of perceived stigma, this argumentation is illogical. For example, in the multivariable analysis, the potential variation in LTFU in regards to sex or education, related to perceived stigma, has effectively been taken into account, as "stigma" is one of the variables included in the model. Thus, the residual association must be explained by other factors. Summarizing, this will thus require a fundamental revision of substantial parts of the Discussion.
5) REFERENCES
The reference list needs careful checking for correctness of content 
6) FINAL REMARKS
The paper may benefit upon resubmission from a careful check on language and style by a native English speaker.
I hope that my comments are fair and useful in revising the manuscript. Comment accepted and incorporated (see table 3) 3.6 Perform global test for specific variables with more than one level
VERSION 1 -AUTHOR RESPONSE
Comment accepted and global test is performed
We computed the p-value specifically for education which has multiple responses.
3.7 explain why several predictor variables don"t appear in Table 3 Comment appreciated but the justification is the variables didn"t appear in table 3 because they did not fulfill the criteria p value less than 0.05 to move to the next analysis . 2) Methods: The issue of patient consent to study participation has once more not been addressed (see first review, specific comment 2.3) Further issues.
3) Suggest using terminology "loss to follow-up" instead of "lost to follow-up" to indicate the study topic. The use of abbreviation also needs harmonizing throughout paper 4) Introduction: Suggest to identify abbreviation PN for partner notification on first occasion.
5) Methods, lines 44-49:
The sample size calculation is still not clear, in particular why an effect size related to PN instead of LTFU was used (also see first review, specific comment 2.3). As this study is observational and essentially involving convenience sampling, the additional data collection was not burdensome. The sample size calculation thus appears to be a minor issue.
6) Methods, page 6, lines 6-12: "Health Facility Index score," should be more clearly defined, particularly because the reference (21) reflects a local report and is difficult to access. 7) Methods, page 6, lines 48-51, A short explanation of VIF is needed as well as an explanation and interpretation of the given model fit (2.02).
8) "Relief of Symptoms" needs to be expanded upon in the discussion section. Explanation would ideally include the type of STIs involved as well as the effectiveness of treatment and the corresponding time course of relief and cure. 9) Table 2 : "Types of STI syndromes" was close to significance and could have been included in the multivariable regression analysis, or at least as part of a sensitivity analysis. In any case, some further discussion is warranted.
10) Discussion, page 9, lines 20-23, It is unclear what is meant by "patients with high quality score." Is this referring to the health facility or to individual patients characteristics?
11) Discussion, page 8, lines 39-41: The term stigma is wrongly used in this context. Probably "less concern" or similar is meant. Why an effect size related to PN is We appreciate the concern. We had two research used instead of LTFU objectives in the cohort population 1) magnitude and associated factors to LTFU 2) factors associated with partner notification Then, we calculated sample size for each. The sample size for LTFU was 895 whereas the sample size for partner notification was 1095. Since we used same population we took the pooled sample size to increase power.
VERSION 2 -AUTHOR RESPONSE
Major issues
6) Methods
Health facility index score should be clearly defined
Explanation added in the revised version 7 Methods
Short explanation of VIF is needed Explanation added in the revised version 8. Relief of symptoms need to be expanded in discussion
The comment is accepted. Early response to treatment can better explain the "relief of symptoms", because one of the indicators of early symptom is relief of symptom (the symptoms of the specific symptom will disappear within a week time starting from 3-4 days following treatment). So that we deleted "relief of symptoms" 9) Table 2 Types of STI syndromes could have been included in multivariate analysis, need some further discussion
We appreciate the reviewers comment that p-value of 0.069 is marginally significant but it didn"t fulfill the predetermined criteria to be included in multivariate logistic regression.
10) Discussion (page 9, line 20-23) Wha is meant by "patients with high quality score" ? Is this referring to HF or individual pts characteristics
The comment is accepted and corrected
11) Discussion
The term stigma is wrongly used in page 8, line 39-41
Comment accepted
